Immunic Statistics Share Statistics Immunic has 95.82M
shares outstanding. The number of shares has increased by 6.37%
in one year.
Shares Outstanding 95.82M Shares Change (YoY) 6.37% Shares Change (QoQ) 6.37% Owned by Institutions (%) 39.92% Shares Floating 95.28M Failed to Deliver (FTD) Shares 6,643 FTD / Avg. Volume 0.4%
Short Selling Information The latest short interest is 8.56M, so 8.94% of the outstanding
shares have been sold short.
Short Interest 8.56M Short % of Shares Out 8.94% Short % of Float 9.11% Short Ratio (days to cover) 10.83
Valuation Ratios The PE ratio is -1 and the forward
PE ratio is -1.69.
Immunic's PEG ratio is
0.02.
PE Ratio -1 Forward PE -1.69 PS Ratio 0 Forward PS 0.6 PB Ratio 5.44 P/FCF Ratio -1.18 PEG Ratio 0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Immunic.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.77,
with a Debt / Equity ratio of 0.05.
Current Ratio 1.77 Quick Ratio 1.77 Debt / Equity 0.05 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.1M Employee Count 91 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -36.84% in the
last 52 weeks. The beta is 1.39, so Immunic's
price volatility has been higher than the market average.
Beta 1.39 52-Week Price Change -36.84% 50-Day Moving Average 0.84 200-Day Moving Average 1.03 Relative Strength Index (RSI) 44.49 Average Volume (20 Days) 1,641,259
Income Statement
Revenue n/a Gross Profit n/a Operating Income -98.05M Net Income -100.51M EBITDA -100.37M EBIT -100.51M Earnings Per Share (EPS) -1
Full Income Statement Balance Sheet The company has 35.67M in cash and 1M in
debt, giving a net cash position of 34.66M.
Cash & Cash Equivalents 35.67M Total Debt 1M Net Cash 34.66M Retained Earnings -511.4M Total Assets 20.52M Working Capital -6.62M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -84.77M
and capital expenditures -264K, giving a free cash flow of -85.03M.
Operating Cash Flow -84.77M Capital Expenditures -264K Free Cash Flow -85.03M FCF Per Share -0.85
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields IMUX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for IMUX is $10,
which is 1090.5% higher than the current price. The consensus rating is "Buy".
Price Target $10 Price Target Difference 1090.5% Analyst Consensus Buy Analyst Count 6
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Apr 15, 2019. It was a
backward
split with a ratio of 1:40.
Last Split Date Apr 15, 2019 Split Type backward Split Ratio 1:40
Scores Altman Z-Score -51.34 Piotroski F-Score 1
